CMS could demand CSR repayments from insurers if Congress doesn't act

If Congress fails to appropriate cost-sharing reduction payments, insurers may have to pay back their 2017 surplus—even if they have already spent it on enrollees.

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us